 |
Dimethylsulfoxide |
|---|---|
| Trade Name | |
| Orphan Indication | Topical treatment for the prevention of soft tissue injury following extravastion of cytotoxic drugs |
| USA Market Approval | USA |
| USA Designation Date | 1997-04-15 00:00:00 |
| Sponsor | Cancer Technologies, Inc.;7301 East 22nd Street, Suite 10E;Tucson, Arizona, 85710 |
